URGN
UroGen Pharma (URGN)
$40
About UroGen Pharma (URGN)
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.
Details
Daily high
$30.45
Daily low
$26.95
Price at open
$26.95
52 Week High
$30.45
52 Week Low
$3.42
Market cap
1.4B
Dividend yield
0.00%
Volume
1.7M
Avg. volume
967,442
P/E ratio
-10.67
UroGen Pharma News
Details
Daily high
$30.45
Daily low
$26.95
Price at open
$26.95
52 Week High
$30.45
52 Week Low
$3.42
Market cap
1.4B
Dividend yield
0.00%
Volume
1.7M
Avg. volume
967,442
P/E ratio
-10.67